Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

ISSN: 2253-1556

Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

Latest articles:

- 5 records -

Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments

Zhao F, Zhao J, Wei K, Jiang P, Shi Y, Chang C, Zheng Y, Shan Y, Li Y, He B, Zhou M, Liu J, Li L, Guo S, He D

ImmunoTargets and Therapy 2024, 13:259-271

Published Date: 16 May 2024

The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review

Berhan A, Damtie S, Almaw A, Legesse B, Sharew B, Getie B, Erkihun M, Solomon Y

ImmunoTargets and Therapy 2024, 13:235-246

Published Date: 26 April 2024

Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies

Shurin MR, Wheeler SE

ImmunoTargets and Therapy 2024, 13:215-234

Published Date: 25 April 2024

Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study

Zhang H, Xu A, Li X, Pan B, Wan X

ImmunoTargets and Therapy 2024, 13:205-214

Published Date: 12 April 2024

Read more articles